ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,745Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2056

$551K Total Retail Price of All Prescriptions

Rank: 45 out of 2056

387 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 11,463 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 683 646 1 3
SIMVASTATIN 562 553 2 2
LISINOPRIL 529 483 3 1
FUROSEMIDE 411 394 4 9
WARFARIN SODIUM 406 389 5 12
OMEPRAZOLE 389 326 6 4
POTASSIUM CHLORIDE 353 328 7 18
CITALOPRAM HBR 319 304 8 15
SERTRALINE HCL 229 210 9 25
HYDROCODONE-ACETAMINOPHEN 228 212 S3 10 5
DONEPEZIL HCL 221 221 11 37
AMLODIPINE BESYLATE 213 213 12 6
METOPROLOL TARTRATE 202 194 13 11
HYDROCHLOROTHIAZIDE 198 179 14 7
NAMENDA 197 197 15 62
METFORMIN HCL 195 175 16 8
METOPROLOL SUCCINATE 195 186 16 19
LOSARTAN POTASSIUM 168 165 18 13
RANITIDINE HCL 163 136 19 22
LOVASTATIN 152 122 20 16
DIGOXIN 148 148 21 53
OXYCODONE HCL 146 136 S2 22 24
ATENOLOL 135 135 23 10
ALLOPURINOL 135 122 23 32
TRAMADOL HCL 124 99 25 27
PREDNISONE 120 110 26 38
TAMSULOSIN HCL 117 104 27 28
TRAZODONE HCL 115 108 28 21
LANTUS 107 96 29 41
GABAPENTIN 106 101 30 14
PRAVASTATIN SODIUM 102 89 31 20
RISPERIDONE 97 85 32 48
FENTANYL 94 91 S2 33 56
POLYETHYLENE GLYCOL 3350 92 82 34 50
DILTIAZEM ER 86 86 35 129
GLIPIZIDE 82 60 36 39
CARVEDILOL 81 69 37 35
CARBIDOPA-LEVODOPA 77 76 38 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 72 39 34
ATORVASTATIN CALCIUM 75 71 40 17
SPIRONOLACTONE 72 59 41 63
DIVALPROEX SODIUM 70 33 42 69
TRIAMTERENE-HCTZ 65 48 43 46
IPRATROPIUM-ALBUTEROL 62 62 44 137
QUETIAPINE FUMARATE 61 61 45 61
AMITRIPTYLINE HCL 61 44 R 45 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 53 47 116
OXYBUTYNIN CHLORIDE 59 47 48 79
TRIAMCINOLONE ACETONIDE 58 58 49 81
PROAIR HFA 56 35 50 29
PAROXETINE HCL 54 52 51 58
DILTIAZEM 24HR CD 53 41 52 120
FLUOXETINE HCL 52 44 53 33
CLONIDINE HCL 51 44 54 92
MIRTAZAPINE 50 50 55 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.